Revealing novel, latent subsets of patients with morphoea through principal component analysis

Br J Dermatol. 2022 Jan;186(1):193-195. doi: 10.1111/bjd.20748. Epub 2021 Oct 21.

Authors

L F Abbas¹, A K Joseph¹, S Prasad¹, J L Zhu¹, K S Fitch^{2

3}, R Haley⁴, K S Torok^{2

3}, H T Jacobe¹

Affiliations

¹ University of Texas Southwestern Medical Center, Dallas, TX, USA.
² University of Pittsburgh Scleroderma Center, Pittsburgh, PA, USA.
³ Children's Hospital of Pittsburgh, Pediatric Rheumatology, Pittsburgh, PA, USA.
⁴ Department of Internal Medicine, University of Texas Southwestern Medical Center, Dallas, TX, USA.

PMID: 34510409
DOI: 10.1111/bjd.20748

No abstract available

Publication types

Letter
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't

MeSH terms

Humans
Principal Component Analysis
Scleroderma, Localized*

Grants and funding